4-(6-异氰吡啶-2-基)吗啉 | 884507-15-7

• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: 4-(6-异氰吡啶-2-基)吗啉
• 中文别名: 4-(6-异氰酰基吡啶-2-基)吗啉
• 英文名称: 4-(6-Isocyanatopyridin-2-yl)morpholine
• CAS: 884507-15-7
• 化学式: C₁₀H₁₁N₃O₂
• mdl: MFCD08435861
• 分子量: 205.21
• InChiKey: RYYZXDNHAQDJTI-UHFFFAOYSA-N

物化性质

• 沸点：
  127 °C
• 密度：
  1.27±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  54.8
• 氢给体数：
  0
• 氢受体数：
  5

安全信息

• 海关编码：
  2934999090

反应信息

• 作为反应物：
  描述：

  6-Chloro-12-(2-piperidin-4-ylethoxy)-2,4,8,18,22-pentaazatetracyclo[14.3.1.1(3,7).1(9,13)]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaene tris(trifluoroacetate) 、 4-(6-异氰吡啶-2-基)吗啉 生成 4-(2-{[6-Chloro-2,4,8,18,22-pentaazatetracyclo[14.3.1.1(3,7).1(9,13)]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaen-12-yl]oxy}ethyl)-N-(6-morpholin-4-ylpyridin-2-yl)piperidine-1-carboxamide tris(trifluoroacetate)
  参考文献：
  名称：

  MACROCYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS

  摘要：

  本发明涉及公式I的大环化合物，或其药学上可接受的盐或季铵盐，其中构成成员在此提供，以及它们的组合物和使用方法，它们是JAK / ALK抑制剂，可用于治疗JAK / ALK相关疾病，包括例如炎症和自身免疫性疾病以及癌症。

  公开号：

  US20090286778A1

文献信息

• [EN] GALACTOPYRANOSYL DERIVATIVES USEFUL AS MEDICAMENTS<br/>[FR] DÉRIVÉS DE GALACTOPYRANOSYLE UTILES EN TANT QUE MÉDICAMENTS
  申请人：UNIV GENT

  公开号：WO2014001204A1

  公开（公告）日：2014-01-03

  This invention relates to carbamate-containing or thiocarbamate-containing galacto-pyranosyl compounds useful as therapeutic agents and being represented by the structural formula (II), wherein: X is O or S, R is selected from the group consisting of C1-8 alkyl, C3-10 cycloalkyl, aryl-C1-4 alkyl, heterocyclyl-C1-4 alkyl, cycloalkyl-C1-4 alkyl, aryl and heterocyclyl, wherein R is optionally substituted with one or more R9; R2, R3, R4, R6 and R7 are independently selected from the group consisting of hydroxyl and protected hydroxyl groups; R5 is selected from the group consisting C6-30 alkyl and arylalkyl; R8 is C6-30 alkyl; and each R9 is independently selected from the group consisting of halogen, hydroxy, trifluoromethyl, trifluoromethoxy, C1-8 alkoxy, C1-6 alkyl, cyano, methylthio, phenyl, phenoxy, chloromethyl, dichloromethyl, chloro-difluoromethyl, acetyl, nitro, benzyl, heterocyclyl and di-C1-4 alkyl-amino, or a pharmaceutically acceptable salt thereof.

  这项发明涉及含有碳酸酯或硫代碳酸酯的半乳糖基化合物，可作为治疗剂，并由结构式（II）表示，其中：X为O或S，R从以下组中选择：C1-8烷基、C3-10环烷基、芳基-C1-4烷基、杂环基-C1-4烷基、环烷基-C1-4烷基、芳基和杂环基，其中R可选择性地被一个或多个R9取代；R2、R3、R4、R6和R7独立地选自羟基和保护羟基基团；R5选自C6-30烷基和芳基烷基；R8为C6-30烷基；每个R9独立地选自卤素、羟基、三氟甲基、三氟甲氧基、C1-8烷氧基、C1-6烷基、氰基、甲硫基、苯基、苯氧基、氯甲基、二氯甲基、氯二氟甲基、乙酰基、硝基、苄基、杂环基和二C1-4烷基氨基，或其药用可接受盐。
• HETEROCYCLIC COMPOUNDS AND THEIR USE AS GLYCOGEN SYNTHASE KINASE 3 INHIBITORS
  申请人：ABBVIE DEUTSCHLAND GMBH & CO. KG

  公开号：US20140148458A1

  公开（公告）日：2014-05-29

  The present invention relates to a heterocyclic compound of the general formula (I) and their use and preparation, methods of making the compounds, compositions containing at least one of said compounds, and methods of treatment using at least one compound. In particular, compounds of the general formula (I) are useful for inhibiting glycogen synthase kinase 3 (GSK-3),

  本发明涉及一种一般式（I）的杂环化合物及其使用和制备、制备该化合物的方法、含有至少一种该化合物的组合物以及使用至少一种该化合物的治疗方法。特别地，一般式（I）的化合物对于抑制糖原合酶激酶3（GSK-3）是有用的。
• Macrocyclic compounds and their use as kinase inhibitors
  申请人：Combs Andrew Paul

  公开号：US08871753B2

  公开（公告）日：2014-10-28

  The present invention relates to macrocyclic compounds of Formula I: or pharmaceutically acceptable salts thereof or quaternary ammonium salts thereof wherein constituent members are provided hereinwith, as well as their compositions and methods of use, which are JAK/ALK inhibitors useful in the treatment of JAK/ALK-associated diseases including, for example, inflammatory and autoimmune disorders, as well as cancer.

  本发明涉及公式I的大环化合物，其药学上可接受的盐或季铵盐，其中组成成分在此提供，以及它们的组合物和使用方法，它们是JAK/ALK抑制剂，对于治疗JAK/ALK相关疾病，包括炎症和自身免疫性疾病以及癌症有用。
• Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors
  申请人：Abbott GmbH & Co. KG

  公开号：EP2535336A1

  公开（公告）日：2012-12-19

  The present invention relates to a heterocyclic compound of the general formula (I) and their use and preparation, methods of making the compounds, compositions containing at least one of said compounds, and methods of treatment using at least one compound. In particular, compounds of the general formula (I) are useful for inhibiting glycogen synthase kinase 3 (GSK-3),

  本发明涉及通式（I）的杂环化合物 及其用途和制备方法、化合物的制造方法、含有至少一种所述化合物的组合物以及使用至少一种化合物进行治疗的方法。通式（I）化合物尤其适用于抑制糖原合酶激酶 3（GSK-3）、
• GALACTOPYRANOSYL DERIVATIVES USEFUL AS MEDICAMENTS
  申请人：Universiteit van Gent

  公开号：EP2877480A1

  公开（公告）日：2015-06-03